Immediate Impact
1 from Science/Nature 65 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Monica Daigl being referenced
Clinical value of atezolizumab + bevacizumab for first-line unresectable hepatocellular carcinoma (HCC): A network meta-analysis.
2020
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Monica Daigl | 126 | 270 | 49 | 98 | 16 | 470 | |
| F. Sauvaget | 102 | 220 | 35 | 57 | 22 | 423 | |
| L.H. Noël | 59 | 177 | 53 | 82 | 16 | 447 | |
| Venkateswarlu Kondragunta | 106 | 136 | 19 | 66 | 22 | 559 | |
| V. Ladam-Marcus | 186 | 153 | 9 | 73 | 14 | 473 | |
| Bruno Dino Bodini | 74 | 292 | 34 | 74 | 22 | 520 | |
| Jun Kang | 130 | 180 | 12 | 90 | 24 | 471 | |
| Antonio Fraga | 110 | 155 | 26 | 25 | 18 | 550 | |
| Jan Broekroelofs | 142 | 173 | 51 | 38 | 14 | 414 | |
| Bruno Iovene | 38 | 496 | 19 | 111 | 20 | 569 | |
| John M. Richmond | 102 | 138 | 47 | 57 | 14 | 428 |
All Works
Login with ORCID to disown or claim papers
Loading papers...